China SXT Pharmaceuticals, Inc. files 6-K

China SXT Pharmaceuticals, Inc. entered into a sales agreement to issue and sell up to $100,000,000 of its Class A ordinary shares through an at-the-market offering. The agreement with Univest Securities, LLC, acting as sales agent, outlines the terms for selling shares on the Nasdaq Capital Market or other trading venues.